共 29 条
- [1] Arme P., Analyse d’incidence en pharmacovigilance: application à la notification spontanée, (1991)
- [2] Auriche M., Approche bayésienne de l’imputabilité des phénomènes indésirables aux médicaments, Thérapie, 40, pp. 301-306, (1985)
- [3] Begaud B., Evreux J.C.L., Jouglard J.C., Lagier G., Imputabilité des effets inattendus ou toxiques des médicaments: actualisation de la méthode utilisée en France, Thérapie, 40, pp. 111-114, (1985)
- [4] Bottiger L.E., Westerholm B., Drug-induced blood dyscrasias in Sweden, British Medical Journal, 3, (1973)
- [5] Bryant C.D., Norman G.R., Expressions of probability: words and numbers, New England Journal of Medicine, 302, (1980)
- [6] WHO co-operative trial on primary prevention of ischaemic heart-disease using clofibrate to lower serum cholesterol: mortality follow-up, Lancet, 2, pp. 279-385, (1980)
- [7] Feinstein AR.I., Clinical epidemiology, (1985)
- [8] Hutchinson T.A., Leventhal J.M., Kramer M.S., Kirch F.E., Lipman A.G., Et al., An algorithm for the operational assessment of adverse drug reactions: II. Demonstration of reproducibility and validity, Journal of the American Medical Association, 242, pp. 633-638, (1979)
- [9] Karen F.E., Lasagna L., Towards the operational identification of adverse drug reactions, Clinical Pharmacology and Therapeutics, 21, pp. 247-254, (1977)
- [10] Kenney R.M., Between never and always, New England Journal of Medicine, 305, pp. 1097-1098, (1981)